Cargando…
Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome
BACKGROUND: Pregnancy failure and placenta mediated pregnancy complications affect > 25% of pregnancies. Although there is biological plausibility for a procoagulant mechanism underlying some of these events, antithrombotic intervention trials demonstrate limited benefit, possibly through lack of...
Autores principales: | Fishel, Simon, Baker, Deborah, Elson, Janine, Ragunath, Maha, Atkinson, Glenn, Shaker, Adel, Omar, Ahmed, Kazem, Rahnuma, Beccles, Ashley, Greer, Ian A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006578/ https://www.ncbi.nlm.nih.gov/pubmed/27440469 http://dx.doi.org/10.1016/j.ebiom.2016.06.024 |
Ejemplares similares
-
Corrigendum to “Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome” [EBioMedicine 10 (2016) 299-305]
por: Fishel, Simon, et al.
Publicado: (2016) -
Thrombotic Disorders and Antithrombotic Treatments Special Issue
por: Micco, Pierpaolo Di
Publicado: (2022) -
Hydroxychloroquine as an Immunomodulatory and Antithrombotic Treatment in Antiphospholipid Syndrome
por: Arachchillage, Deepa J., et al.
Publicado: (2023) -
The annexins
por: Moss, Stephen E, et al.
Publicado: (2004) -
Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
por: Camarero, Tamara García, et al.
Publicado: (2020)